The peptide landscape in the United Kingdom has matured rapidly, bringing heightened expectations for analytical rigour, cold‑chain reliability, and documentation that stands up to institutional scrutiny. Within this environment, CJC‑1295
The peptide landscape in the United Kingdom has matured rapidly, bringing heightened expectations for analytical rigour, cold‑chain reliability, and documentation that stands up to institutional scrutiny. Within this environment, CJC‑1295